Cite

    Kado, J. et al. (2020). Subcutaneous administration of benzathine benzylpenicillin G has favourable pharmacokinetic characteristics for the prevention of rheumatic heart disease compared with intramuscular injection: a randomized, crossover, population pharmacokinetic study in healthy adult volunteers. Journal of antimicrobial chemotherapy. pp. 2951-2959. [Online].